Invention Grant
- Patent Title: 2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation
-
Application No.: US17320003Application Date: 2021-05-13
-
Publication No.: US11324766B2Publication Date: 2022-05-10
- Inventor: Ardythe L. Morrow , David S. Newburg , John M. McCoy
- Applicant: Glycosyn LLC
- Applicant Address: US MA Waltham
- Assignee: Glycosyn LLC
- Current Assignee: Glycosyn LLC
- Current Assignee Address: US MA Waltham
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Ingrid A. Beattie
- Main IPC: A61K31/702
- IPC: A61K31/702 ; A61K9/00 ; A61K45/06 ; A61K35/745 ; A61K35/742 ; A61K35/74 ; A23L33/125 ; A23L33/00 ; A23L2/52 ; A61K35/747
Abstract:
The invention provides compositions and methods for utilizing oligosaccharides, such as isolated human milk oligosaccharides, to attenuate a respiratory pathogen infection-induced host inflammation and/or to promote recovery from a respiratory pathogen infection-induced host inflammation in a subject.
Public/Granted literature
- US20210353653A1 2'-FUCOSYLLACTOSE FOR THE PREVENTION AND TREATMENT OF CORONAVIRUS-INDUCED INFLAMMATION Public/Granted day:2021-11-18
Information query
